<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8545338</article-id>
    <article-id pub-id-type="pmid">33961020</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btab319</article-id>
    <article-id pub-id-type="publisher-id">btab319</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Systems Biology</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>IntAct App: a Cytoscape application for molecular interaction network visualization and analysis</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7876-6503</contrib-id>
        <name>
          <surname>Ragueneau</surname>
          <given-names>Eliot</given-names>
        </name>
        <aff><institution>European Bioinformatics Institute (EMBL-EBI), European Molecular Biology Laboratory, Wellcome Genome Campus,</institution> Hinxton, Cambridgeshire CB10 1SD, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Shrivastava</surname>
          <given-names>Anjali</given-names>
        </name>
        <aff><institution>European Bioinformatics Institute (EMBL-EBI), European Molecular Biology Laboratory, Wellcome Genome Campus,</institution> Hinxton, Cambridgeshire CB10 1SD, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Morris</surname>
          <given-names>John H</given-names>
        </name>
        <aff><institution>Resource for Biocomputing, Visualization, and Informatics, Department of Pharmaceutical Chemistry, University of California</institution>, San Francisco, CA 94158 2517, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>del-Toro</surname>
          <given-names>Noemi</given-names>
        </name>
        <aff><institution>European Bioinformatics Institute (EMBL-EBI), European Molecular Biology Laboratory, Wellcome Genome Campus,</institution> Hinxton, Cambridgeshire CB10 1SD, <country country="GB">UK</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Hermjakob</surname>
          <given-names>Henning</given-names>
        </name>
        <xref rid="btab319-cor1" ref-type="corresp"/>
        <aff><institution>European Bioinformatics Institute (EMBL-EBI), European Molecular Biology Laboratory, Wellcome Genome Campus,</institution> Hinxton, Cambridgeshire CB10 1SD, <country country="GB">UK</country></aff>
        <!--hhe@ebi.ac.uk-->
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Porras</surname>
          <given-names>Pablo</given-names>
        </name>
        <xref rid="btab319-cor1" ref-type="corresp"/>
        <aff><institution>European Bioinformatics Institute (EMBL-EBI), European Molecular Biology Laboratory, Wellcome Genome Campus,</institution> Hinxton, Cambridgeshire CB10 1SD, <country country="GB">UK</country></aff>
        <!--pporras@ebi.ac.uk-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Cowen</surname>
          <given-names>Lenore</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btab319-cor1">To whom correspondence should be addressed. <email>hhe@ebi.ac.uk</email> or <email>pporras@ebi.ac.uk</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>10</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-05-07">
      <day>07</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>07</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <volume>37</volume>
    <issue>20</issue>
    <fpage>3684</fpage>
    <lpage>3685</lpage>
    <history>
      <date date-type="received">
        <day>28</day>
        <month>1</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>08</day>
        <month>4</month>
        <year>2021</year>
      </date>
      <date date-type="editorial-decision">
        <day>24</day>
        <month>4</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>27</day>
        <month>4</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btab319.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>IntAct App is a Cytoscape 3 application that grants in-depth access to IntAct’s molecular interaction data. It build networks where nodes are interacting molecules (mainly proteins, but also genes, RNA, chemicals…) and edges represent evidence of interaction. Users can query a network by providing its molecules, identified by different fields and optionally include all their interacting partners in the resulting network. The app offers three visualizations: one only displaying interactions, another representing every evidence and the last one emphasizing evidence where mutated versions of proteins were used. Users can also filter networks and click on nodes and edges to access all their related details. Finally, the application supports automation of its main features <italic toggle="yes">via</italic> Cytoscape commands.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>Implementation available at <ext-link xlink:href="https://apps.cytoscape.org/apps/intactapp" ext-link-type="uri">https://apps.cytoscape.org/apps/intactapp</ext-link>, while the source code is available at <ext-link xlink:href="https://github.com/EBI-IntAct/IntactApp" ext-link-type="uri">https://github.com/EBI-IntAct/IntactApp</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>EMBL core funding</institution>
          </institution-wrap>
        </funding-source>
        <award-id>OTAR-044</award-id>
        <award-id>OTAR02-048</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Wellcome Trust</institution>
            <institution-id institution-id-type="DOI">10.13039/100010269</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>#3367</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>NIGMS</institution>
            <institution-id institution-id-type="DOI">10.13039/100000057</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>P41 GM103504</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="2"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>IntAct is an open-source molecular interaction database which captures experimental evidence from the literature in high detail (<xref rid="btab319-B5" ref-type="bibr">Orchard <italic toggle="yes">et al.</italic>, 2014</xref>), following the deep curation model developed in the IMEx Consortium (<xref rid="btab319-B6" ref-type="bibr">Porras <italic toggle="yes">et al.</italic>, 2020</xref>). One of the challenges faced by IntAct is to provide efficient ways to access and display the rich detail of its data. Cytoscape is an answer to this issue, as it grants biologists unparalleled flexibility to visualize, manipulate and analyse networks, especially through the many tools available as Cytoscape apps (<xref rid="btab319-B7" ref-type="bibr">Shannon <italic toggle="yes">et al.</italic>, 2003</xref>).</p>
    <p>Different tools, such as PSICQUIC (<xref rid="btab319-B1" ref-type="bibr">del-Toro <italic toggle="yes">et al.</italic>, 2013</xref>) or the BioGateway App (<xref rid="btab319-B3" ref-type="bibr">Holmås <italic toggle="yes">et al.</italic>, 2020</xref>) already provide access to</p>
    <p>IntAct’s molecular interactions. However, they do not represent the full depth of detail in IntAct data as they are meant to integrate other databases as well, and therefore use a shallow model of the available data.</p>
    <p>IntAct App aims to provide full access to the different layers of IntAct, ensuring their readability by offering different predefined styles, nested navigation and filtering capabilities on multiple levels.</p>
  </sec>
  <sec>
    <title>2 Features</title>
    <p>Users can build IntAct networks by querying for a set of molecule names, identifiers or descriptors. These will define the network participants, visualizing interactions between them and, optionally, all interacting partners. Ambiguous symbols or identifiers, matching more than one molecule in IntAct, can be dealt with thanks to a preview panel displaying all matches found per search term. IntAct App provides two query modes that are distinct in the way this ambiguity is dealt with:
</p>
    <list list-type="bullet">
      <list-item>
        <p>‘<italic toggle="yes">Exact query</italic>’, to minimize the possibility of ambiguity. It should be used when the user has precise, unambiguous identifiers. It requires complete identifiers or gene names.</p>
      </list-item>
      <list-item>
        <p>‘<italic toggle="yes">Fuzzy search</italic>’, a broader search to collect everything associated with the given terms. It also allows partial matches of names and descriptions for the target molecules.</p>
      </list-item>
    </list>
    <p>IntAct App provides three styling options, or ‘views’, of its networks. The ‘Evidence’ view represents every evidence (one interaction observed by one technology in one publication) as a distinct edge. The ‘Summary’ view collapses all interaction evidence between each pair of molecules into a single edge. Finally, the ‘Mutation’ view also separates each evidence but highlights edges in which one of the participants is mutated.</p>
    <p>To highlight cross-species interactions, molecules are styled according to the species they belong to with a palette based on their taxonomy.</p>
    <p>IntAct App allows style customization via the interactive legend, so that users can reassign node color according to their preference.</p>
    <p>Selection of IntAct network elements triggers the display of all information relative to them in the application panel. Available data are fully described in the user guide (<ext-link xlink:href="https://ebi-intact.github.io/IntActApp/" ext-link-type="uri">https://ebi-intact.github.io/IntActApp/</ext-link>).</p>
    <p>The drop down information menus on this panel can also be used to filter the data according to different criteria, such as the confidence score associated with the interactions (<xref rid="btab319-B8" ref-type="bibr">Villaveces <italic toggle="yes">et al.</italic>, 2015</xref>), interaction types, detection methods or molecule species.</p>
    <p>IntAct App also supports the creation of sub networks, Cytoscape session saves and its core features are available via command line, thus allowing automation and scripting access (<ext-link xlink:href="https://ebi-intact.github.io/IntActApp/automation_support" ext-link-type="uri">https://ebi-intact.github.io/IntActApp/automation_support</ext-link>).</p>
  </sec>
  <sec>
    <title>3 Use case</title>
    <p>Angiotensin-converting enzyme 2 (ACE2) is a crucial protein in the COVID-19 pandemic as it has been identified as the entrance receptor for the surface spike glycoprotein (S) of SARS-CoV-2 (<xref rid="btab319-B2" ref-type="bibr">Hoffmann <italic toggle="yes">et al.</italic>, 2020</xref>). In IntAct App, a fuzzy search with the term ‘ACE2’ builds a network with eight orthologs of ACE2, including the human processed form. Two yeast hits, which map to a completely different protein sharing the same symbol, can be easily discarded through the preview panel.</p>
    <p>The human ACE2 (Q9BYF1) shows evidence of interaction with 7 Spike proteins coming from different viruses, including human SARS-CoV (MI Score: 0.98) and SARS-CoV-2 (MI Score: 0.99). Shifting to ‘Evidence’ view allows to see the full extent of evidence behind these well-characterized interactions. The ‘Mutation’ view (<xref rid="btab319-F1" ref-type="fig">Fig. 1</xref>) tells that mutations on both Spike and ACE2 might have an impact on their binding. Several of these mutations were found to increase the interaction strength, among which N501T, a mutation of the Spike protein on the same position as N501Y, which is found on the highly transmissible VOC 202012/01 strain (<xref rid="btab319-B4" ref-type="bibr">Leung <italic toggle="yes">et al.</italic>, 2021</xref>) and other emerging strains. The information recorded in IntAct highlights the importance of the N501 residue in Spike-ACE2 binding and could help refine current hypothesis about the increased transmissibility of some of these strains.</p>
    <fig position="float" id="btab319-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>ACE2 fuzzy search filtered result on Mutation view. Each interaction evidence is shown as a separate edge. Molecules and interactions with mutation information are highlighted in pink. SARS-CoV data has been hidden to focus on SARS-CoV-2</p>
      </caption>
      <graphic xlink:href="btab319f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>4 Conclusion</title>
    <p>IntAct App allows for the representation of molecular interaction networks derived from the IntAct database, providing unprecedented access to the full level of experimental detail featured in IntAct records. For the first time, users can easily navigate and filter details about interaction detection methods, experimental hosts, binding regions or mutations affecting interaction outcome, using customizable and flexible styling options to focus on different aspects of the data. The app is also meant to complement IntAct’s website, providing support for representation of large networks.</p>
    <p>Planned development will focus on providing advanced query types, for example allowing the construction of full interactomes, and exploring integration capabilities with other apps and functionalities of Cytoscape.</p>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors would like to acknowledge the colleagues that provided feedback during the development of this application: Birgit Meldal, Kalpana Panneerselvam and Livia Perfetto. They would also like to acknowledge our testers: Alistair MacDougall, Andrés Baselga Fraga, Carola Gómez-Rodríguez, John Salamon, Miguel Andrade, Ruth Isserlin, Sandra Orchard and Théo Gauvrit.</p>
    <sec>
      <title>Funding</title>
      <p>The IntAct team at EMBL-EBI received funding from EMBL core funding, Open Targets (grant agreements OTAR-044 and OTAR02-048) and the Wellcome Trust (Biomedical Resources grant INVAR #3367). J.H.M.’s work is funded by NIGMS P41 GM103504. The work of E.R. was supported by the Higher Education, Research and Innovation Department of the French Embassy to the United Kingdom.</p>
      <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btab319-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>del-Toro</surname><given-names>N.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2013</year>) <article-title>A new reference implementation of the PSICQUIC web service</article-title>. <source>Nucleic Acids Res</source>., <volume>41</volume>, <fpage>W601</fpage>–<lpage>W606</lpage>.<pub-id pub-id-type="pmid">23671334</pub-id></mixed-citation>
    </ref>
    <ref id="btab319-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoffmann</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor</article-title>. <source>Cell</source>, <volume>181</volume>, <fpage>271</fpage>–<lpage>280.e8</lpage>.<pub-id pub-id-type="pmid">32142651</pub-id></mixed-citation>
    </ref>
    <ref id="btab319-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Holmås</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>The cytoscape BioGateway app: explorative network building from an RDF store</article-title>. <source>Bioinformatics</source>, <volume>36</volume>, <fpage>1966</fpage>–<lpage>1967</lpage>.</mixed-citation>
    </ref>
    <ref id="btab319-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leung</surname><given-names>K.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) <article-title>Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020</article-title>. <source>Eurosurveill</source>, <volume>26</volume>, <fpage>2002106</fpage>.</mixed-citation>
    </ref>
    <ref id="btab319-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Orchard</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2014</year>) <article-title>The MIntAct project–IntAct as a common curation platform for 11 molecular interaction databases</article-title>. <source>Nucleic Acids Res</source>., <volume>42</volume>, <fpage>D358</fpage>–<lpage>D363</lpage>.<pub-id pub-id-type="pmid">24234451</pub-id></mixed-citation>
    </ref>
    <ref id="btab319-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Porras</surname><given-names>P.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Toward a unified open access dataset of molecular interactions</article-title>. <source>Nat. Commun</source>., <volume>11</volume>, <fpage>1</fpage>–<lpage>12</lpage><pub-id pub-id-type="pmid">31911652</pub-id></mixed-citation>
    </ref>
    <ref id="btab319-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shannon</surname><given-names>P.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2003</year>) <article-title>Cytoscape: a software Environment for integrated models of biomolecular interaction networks</article-title>. <source>Genome Res</source>., <volume>13</volume>, <fpage>2498</fpage>–<lpage>2504</lpage>.<pub-id pub-id-type="pmid">14597658</pub-id></mixed-citation>
    </ref>
    <ref id="btab319-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Villaveces</surname><given-names>J.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2015</year>) <article-title>Merging and scoring molecular interactions utilising existing community standards: tools, use-cases and a case study</article-title>. <source>Database</source>, <volume>2015</volume>, <fpage>bau131</fpage>.<pub-id pub-id-type="pmid">25652942</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
